SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-299064
Filing Date
2014-08-07
Accepted
2014-08-07 06:04:08
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d754969d10q.htm 10-Q 498078
2 EX-10.6 d754969dex106.htm EX-10.6 210107
3 EX-31.1 d754969dex311.htm EX-31.1 9186
4 EX-31.2 d754969dex312.htm EX-31.2 9571
5 EX-32 d754969dex32.htm EX-32 4231
  Complete submission text file 0001193125-14-299064.txt   3308355

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pvct-20140630.xml EX-101.INS 363365
7 XBRL TAXONOMY EXTENSION SCHEMA pvct-20140630.xsd EX-101.SCH 44191
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pvct-20140630_cal.xml EX-101.CAL 43145
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pvct-20140630_def.xml EX-101.DEF 110436
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pvct-20140630_lab.xml EX-101.LAB 309831
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pvct-20140630_pre.xml EX-101.PRE 185529
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36457 | Film No.: 141021626
SIC: 2834 Pharmaceutical Preparations